FCF Margin % is calculated as Free Cash Flow divided by its Revenue. NuVasive's Free Cash Flow for the
three
months ended in Jun. 2023 was $-0 Mil. NuVasive's Revenue for the
three
months ended in Jun. 2023 was $318 Mil. Therefore, NuVasive's FCF Margin % for the quarter that ended in Jun. 2023 was -0.16%.
The historical rank and industry rank for NuVasive's FCF Margin % or its related term are showing as below:
NUVA'
s FCF Margin % Range Over the Past 10 Years
Min: -2.35 Med: 6.46 Max: 9.95
Current: -0.27
During the past 13 years, the highest FCF Margin % of NuVasive was 9.95%. The lowest was -2.35%. And the median was 6.46%.
NUVA's FCF Margin % is not ranked
in the Medical Devices & Instruments industry.
Industry Median: -7.13
vs NUVA: -0.27
NuVasive FCF Margin % Historical Data
The historical data trend for NuVasive's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, NuVasive's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
NuVasive's FCF Margin % Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, NuVasive's FCF Margin % distribution charts can be found below:
* The bar in red indicates where NuVasive's FCF Margin % falls into.
NuVasive FCF Margin % Calculation
FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.
NuVasive's FCF Margin for the fiscal year that ended in Dec. 2022 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NuVasive FCF Margin % Related Terms
Thank you for viewing the detailed overview of NuVasive's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.
NuVasive Inc is a medical technology company focused on developing, manufacturing, selling and providing procedural solutions for spine surgery, with a guiding purpose to transform surgery, advance care and change lives. The company has a portfolio of procedurally integrated spine surgery solutions, including surgical access instruments, spinal implants, fixation systems, biologics, and enabling technologies, as well as systems and services for intraoperative neuromonitoring. It also develop and sell magnetically adjustable implant systems for spine and specialized orthopedic procedures.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
NUVA has been successfully added to your 